|
 |
 |
|
 |
 |
|
MAY 15, 2008
Managing the Adverse Event Profile of EGFR Inhibitors
A Satellite Symposium during the
Oncology Nursing Society’s 33rd Annual Congress
Philadelphia Marriott Downtown
Grand Ballroom A, B & F
Philadelphia, Pennsylvania
Chair:
Mario E. Lacouture, MD
Northwestern University
Chicago, Illinois
Click
here to register
for this program |
 |
|
F A C
U L T
Y |
 |
|
|
Surendra Basti, MD
Northwestern Laser Vision Center
Northwestern University
Chicago, Illinois
Barbara Burtness, MD
Fox Chase Cancer Center
Philadelphia, Pennsylvania |
Mario E. Lacouture, MD
Robert H. Lurie Comprehensive
Cancer Center
Northwestern University
Chicago, Illinois
David R. Spigel, MD
Sarah Cannon Research Institute
Nashville, Tennessee |
Gail Wilkes, RN, MSN, OCN®
Boston Medical Center
Boston, Massachusetts |
|
|
|
S C I
E N T
I F I
C
A G E N D A |
|
|
|
11:00 am
Lunch
11:30 am
Welcome/Introduction
Mario E. Lacouture, MD
11:35 am
The role of EGFR inhibitors in solid tumors
Barbara Burtness, MD
11:55 am
Overview of adverse event profile of EGFR inhibitors
Gail Wilkes, RN, MSN, OCN®
12:15 pm
Management of dermatologic events associated with EGFR inhibitors
Mario E. Lacouture, MD
12:35 pm
Ophthalmologic toxicities and their management
Surendra Basti, MD
12:55 pm
The management of infusion-related hypersensitivity reactions of chimeric monoclonal antibodies
David R. Spigel, MD
1:15 pm
Panel Discussion
1:30 pm
Adjourn
Meeting space has been assigned to provide a satellite symposium funded by (Exhibitors Name)
via an unrestricted educational grant during the Oncology Nursing Society’s (ONS) 33rd Annual Congress, May 15-18, 2008 in Philadelphia, Pennsylvania. The Oncology Nursing Society’s assignment of meeting space does not imply product endorsement nor does the Oncology Nursing Society assume any responsibility for the educational content.
|
|
|
|
C O N
T I N
U I N
G M
E D I
C A L
E D U
C A T
I O N |
|
|
|
This program has been approved by the American Association of Critical-Care Nurses (AACN) for 2.0 contact hours, CERP A, File number 0508-A020.01/4984 |
|
|
|
W H O
S H O
U L D
A T T
E N D
? |
|
|
|
This educational activity is specifically designed for oncology nurses, nurse practitioners, and other healthcare professionals interested in and/or involved in the care of patients with cancer. |
|
|
|
O B J
E C T
I V E
S |
|
|
|
After successful completion of this educational activity, attendees should be able to:
- Describe and discuss the role of EGFR inhibitors in patients with solid tumors
- Distinguish the various cutaneous adverse events related to EGFR inhibitors and develop management strategies designed to minimize these events
- Identify and manage the ophthalmologic side effects of EGFR inhibition
- Evaluate and manage infusion-related hypersensitivity reactions of chimeric monoclonal antibodies
|
|
|
|
|
R E G
I S T
R A T
I O N |
|
|
|
Click
here to register
for this program
This is a complimentary educational luncheon symposium and space is limited.
To pre-register, registration must be received no later than May 12, 2008. Please register onsite after this date. Contact Imedex at +1 (678) 242 0906 or visit our website at www.imedex.com to ensure that the program is being held as scheduled and to confirm that the meeting is not full.
Imedex does not accept responsibility for covering travel, accommodation or any other costs incurred by registrants in the rare event that this symposium should be canceled for any reason. Every effort will be made to give reasonable notice in the event of cancellation. The event agenda content is subject to change without notice. |
|
|
|
G E N
E R A
L
I N F
O R M
A T I
O N |
|
|
|
Symposium Location
Philadelphia Marriott Downtown
Grand Ballroom – Salons A, B, & F
11:00 AM – 1:30 PM
1201 Market Street
Philadelphia, Pennsylvania 19107
Tel.: +1 (215) 625 2900
Fax: +1 (215) 625 6000
|
|
|
|
O R G
A N I
Z E R |
|
|
|
|
|
©
2008 Imedex®,
LLC. |
|
